These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
827 related articles for article (PubMed ID: 29347874)
21. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Annane D; Sébille V; Bellissant E; Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152 [TBL] [Abstract][Full Text] [Related]
22. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600 [TBL] [Abstract][Full Text] [Related]
23. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Fernández J; Escorsell A; Zabalza M; Felipe V; Navasa M; Mas A; Lacy AM; Ginès P; Arroyo V Hepatology; 2006 Nov; 44(5):1288-95. PubMed ID: 17058239 [TBL] [Abstract][Full Text] [Related]
24. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Schelling G; Stoll C; Kapfhammer HP; Rothenhäusler HB; Krauseneck T; Durst K; Haller M; Briegel J Crit Care Med; 1999 Dec; 27(12):2678-83. PubMed ID: 10628609 [TBL] [Abstract][Full Text] [Related]
26. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. Arabi YM; Aljumah A; Dabbagh O; Tamim HM; Rishu AH; Al-Abdulkareem A; Knawy BA; Hajeer AH; Tamimi W; Cherfan A CMAJ; 2010 Dec; 182(18):1971-7. PubMed ID: 21059778 [TBL] [Abstract][Full Text] [Related]
27. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial. Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145 [TBL] [Abstract][Full Text] [Related]
28. Effect of hydrocortisone versus methylprednisolone on clinical outcomes in oncology patients with septic shock. McDonnell E; Collins R; Hernandez M; Brown ART J Oncol Pharm Pract; 2021 Jan; 27(1):54-62. PubMed ID: 32686618 [TBL] [Abstract][Full Text] [Related]
29. Evaluating the effectiveness and safety of hydrocortisone therapy in cancer patients with septic shock. Nazer L; AlNajjar T; Al-Shaer M; Rimawi D; Hawari F J Oncol Pharm Pract; 2015 Aug; 21(4):274-9. PubMed ID: 24781452 [TBL] [Abstract][Full Text] [Related]
30. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit. Holst LB Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806 [TBL] [Abstract][Full Text] [Related]
31. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Loisa P; Parviainen I; Tenhunen J; Hovilehto S; Ruokonen E Crit Care; 2007; 11(1):R21. PubMed ID: 17306016 [TBL] [Abstract][Full Text] [Related]
32. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes. Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197 [TBL] [Abstract][Full Text] [Related]
33. Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Lyu QQ; Chen QH; Zheng RQ; Yu JQ; Gu XH J Intensive Care Med; 2020 Oct; 35(10):971-983. PubMed ID: 30270720 [TBL] [Abstract][Full Text] [Related]
35. A Randomized Controlled Trial of Corticosteroids in Pediatric Septic Shock: A Pilot Feasibility Study. Menon K; McNally D; O'Hearn K; Acharya A; Wong HR; Lawson M; Ramsay T; McIntyre L; Gilfoyle E; Tucci M; Wensley D; Gottesman R; Morrison G; Choong K; Pediatr Crit Care Med; 2017 Jun; 18(6):505-512. PubMed ID: 28406862 [TBL] [Abstract][Full Text] [Related]
36. Septic shock of early or late onset: does it matter? Roman-Marchant O; Orellana-Jimenez CE; De Backer D; Melot C; Vincent JL Chest; 2004 Jul; 126(1):173-8. PubMed ID: 15249459 [TBL] [Abstract][Full Text] [Related]
37. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Moreno R; Sprung CL; Annane D; Chevret S; Briegel J; Keh D; Singer M; Weiss YG; Payen D; Cuthbertson BH; Vincent JL Intensive Care Med; 2011 Nov; 37(11):1765-72. PubMed ID: 21847649 [TBL] [Abstract][Full Text] [Related]
38. Plasma Cortisol, Aldosterone, and Ascorbic Acid Concentrations in Patients with Septic Shock Do Not Predict Treatment Effect of Hydrocortisone on Mortality. A Nested Cohort Study. Cohen J; Bellomo R; Billot L; Burrell LM; Evans DM; Finfer S; Hammond NE; Li Q; Liu D; McArthur C; McWhinney B; Moore J; Myburgh J; Peake S; Pretorius C; Rajbhandari D; Rhodes A; Saxena M; Ungerer JPJ; Young MJ; Venkatesh B Am J Respir Crit Care Med; 2020 Sep; 202(5):700-707. PubMed ID: 32396775 [No Abstract] [Full Text] [Related]
39. Selepressin, a novel selective vasopressin V Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037 [TBL] [Abstract][Full Text] [Related]
40. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se). Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]